Winter 2024/2025 Vol. 14 Issue 04
-
From the Editor-in-Chief
A New Treatment for Some Brain TumorsA recently approved therapy targets abnormal enzymes produced by gene defects.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Your Results Are AvailableWeb-based patient portals provide immediate access to test results and doctor's notes. But is that a good thing?
by Hester Hill Schnipper
-
Caregiving With Confidence
Addressing Depression Head-onCaregivers may need to advocate for themselves to get mental health support.
by K.J. Bannan
-
Policy Matters
Progress in the Youth E-cigarette EpidemicNew data reveal a decrease in youth e-cigarette use but underscore the need for continued policy and advocacy efforts.
by Brad Davidson, PhD
-
Reducing the Burden of Radiation
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
by Stephen Ornes
-
Making Their Mark
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Cancer Care for Older Adults
Geriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.
by Eric Fitzsimmons
-
Survivor Profile
A Cause for ConcernMargie Wilson is helping Black women understand their risk for endometrial cancer and teaching them not to ignore the warning signs.
by Taayoo Murray
-
Q&A
Solving a Medical MysteryJournalist Lawrence Ingrassia traces the scientific history of a genetic disorder that predisposes families like his to cancer.
by Thomas Celona
-
Get Involved
Treasure TroveThe Pediatric Oncology Treasure Chest Foundation provides toys and gifts to young cancer patients.
by Thomas Celona
-
Facts and Stats
Financial FalloutNearly half of cancer survivors report their treatment left them in debt.
by Thomas Celona
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona